OKUR filings
Corporate insider profile
Jason A. Leverone Filing Activity
Latest reported as Chief Financial Officer of OnKure Therapeutics, Inc. (OKUR).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$1,332.08
- Latest transaction
- Jun 22, 2026
Affiliated corporations
Reported company relationships
Transaction history